Massive ovarian oedema (MOE) is a rare benign condition that can mimic ovarian neoplasms and lead to unnecessary oophorectomy ...
Company rapidly advancing Phase 3 programs designed to deliver best-in-class efficacy with convenient quarterly dosing in ...
FUJIFILM Biosciences, a global leader in the life science market, and NextCell Pharma AB, a clinical-stage company ...
Microfluidic architecture with vascular and tumor chambers recreates perfusion and desmoplastic stroma, enabling longitudinal visualization of PDAC cell–stromal dynamics under near-physiologic flow.
Zirconia is widely regarded as a promising alternative to titanium for bone and dental implants because of its aesthetic ...
Tumors do not communicate only with immune cells, blood vessels, and stromal tissue. A growing body of evidence suggests that ...
Pilot data suggest IV mesenchymal stromal cell therapy may improve signs of canine osteoarthritis with no serious safety signals. Gallant reported new pilot data for an intravenous mesenchymal stromal ...
R3 Stem Cell's trademark for "Regenerative Trifecta" formalizes the brand identity of a clinical protocol used across ...
INmune Bio Inc. (NASDAQ: INMB) (“INmune Bio”), a clinical-stage biotechnology company, and Anthony Nolan, a pioneering UK-based charity ...
Planning for dual launches of bezuclastinib in Systemic Mastocytosis and Gastrointestinal Stromal Tumors (GIST)- Pivotal data from Phase 3 PEAK ...
Nordot on MSN
This is why losing weight may not erase your obesity risk – and how your immune system 'remembers' it for years
You can shed the kilos and normalise your blood tests, yet your immune cells may still act as if you were obese. Scientists ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results